Amanote Research
Register
Sign In
P2.01-93 the Analysis of the Soluble Programmed Death-1 of Lung Cancer Patients With Different Characteristics
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1147
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
H. Zhu
R. Tian
W. Guo
Y. Guo
J. Xu
X. Song
Publisher
Elsevier BV
Related search
Clinical Significance of Soluble Programmed Cell Death-1 and Soluble Programmed Cell Death-Ligand 1 in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
PLoS ONE
Multidisciplinary
MicroRNAs Aid the Assessment of Programmed Death Ligand�1 Expression in Patients With Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Predictive Role of Computed Tomography Texture Analysis in Patients With Metastatic Urothelial Cancer Treated With Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Role of Soluble Programmed Death-1 (sPD-1) and sPD-ligand 1 in Patients With Cystic Echinococcosis
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Erratum To: Analysis of Programmed Death-1 in Patients With Psoriatic Arthritis
Inflammation
Allergy
Immunology
Elevated Serum Soluble Programmed Cell Death Ligand 1 Concentration as a Potential Marker for Poor Prognosis in Small Cell Lung Cancer Patients With Chemotherapy
Respiratory Research
Pulmonary
Respiratory Medicine
Prognostic Impact of CD8 and Programmed Death-Ligand 1 Expression in Patients With Resectable Non-Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
Complete and Sustained Response of Brain Metastases to Programmed Death 1 Antibody Monotherapy in Treatment-Naive Programmed Death Ligand 1–Positive Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.01-79 Neurological Death Is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary